Provided by Tiger Trade Technology Pte. Ltd.

Lunai Bioworks

1.30
-0.0800-5.80%
Post-market: 1.300.00000.00%16:10 EDT
Volume:124.88K
Turnover:168.79K
Market Cap:5.89M
PE:-0.02
High:1.46
Open:1.44
Low:1.23
Close:1.38
52wk High:13.28
52wk Low:1.21
Shares:4.53M
Float Shares:2.87M
Volume Ratio:2.36
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-61.5200
EPS(LYR):-86.2743
ROE:-325.46%
ROA:-9.65%
PB:-0.62
PE(LYR):-0.02

Loading ...

Stock Market: Will S&P 500 Open Up or Down Today?

Benzinga Earnings
·
Yesterday

Top News Today: Stocks Rise After Bond Market Flips in Choppy Trading

Dow Jones
·
Yesterday

Lunai Bioworks Inc: Files for Non Timely 10-K with U.S. SEC

THOMSON REUTERS
·
Sep 30

Lunai Bioworks Inc: Anticipates Reporting a Net Loss for the Fiscal Year Ended June 30, 2026 of About $3.2 Million

THOMSON REUTERS
·
Sep 30

Lunai Bioworks Delays Annual Report Filing After Missing Form 10-K Deadline

Reuters
·
Sep 30

Lunai Bioworks Signs Exclusive Parkinson’s Cellular Phenotyping Deal with Tanaist

Reuters
·
Sep 22

Lunai Bioworks - to Own Collaboration-Generated Results and Intellectual Property

THOMSON REUTERS
·
Sep 22

Lunai Bioworks - Receives Exclusive Rights to Tanaist Cellular Phenotyping Technology for Parkinson's

THOMSON REUTERS
·
Sep 22

Lunai Bioworks (Nasdaq: Lnai) Expands Parkinson's Platform Through Exclusive Tanaist Agreement

THOMSON REUTERS
·
Sep 22

Lunai Bioworks Reports 0.88 AUROC in Structure-Based AChE Inhibitor Screening Model Using NIH Tox21 Data

Reuters
·
Sep 16

Lunai Bioworks Corrects Link to Second Amended Complaint in Naked Short Selling Suit Release

Reuters
·
Sep 04

Lunai Bioworks - Second Amended Complaint Alleges Securities Fraud and Market Manipulation Under Rule 10B-5

THOMSON REUTERS
·
Aug 27

Lunai Bioworks - Files Second Amended Complaint Naming Six Broker-Dealers and Two Principals

THOMSON REUTERS
·
Aug 27

Lunai Bioworks Lawsuit Names Six Broker-Dealers in Alleged Naked Short Selling Scheme

Reuters
·
Aug 27

Lunai Bioworks Signs Collaboration Agreement with BrainStorm Therapeutics on Parkinson’s Disease Research

Reuters
·
Aug 05

Lunai Bioworks - Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

THOMSON REUTERS
·
Aug 05

Lunai Bioworks (Nasdaq: Lnai) Signs Definitive Collaboration Agreement with Brainstorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

THOMSON REUTERS
·
Aug 05

Lunai Bioworks Names 10 Defendants in Alleged Naked Short-Selling Fraud Lawsuit

Reuters
·
Aug 04

Lunai Bioworks announces availability of CEO shareholder letter

Reuters
·
Jun 17

Top Premarket Gainers

MT Newswires Live
·
Jun 17